Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Agitation
ADR ID BADD_A00124
ADR Hierarchy
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.05      Neurological signs and symptoms NEC
17.02.05.012      Agitation
19      Psychiatric disorders
19.06      Anxiety disorders and symptoms
19.06.02      Anxiety symptoms
19.06.02.001      Agitation
Description A disorder characterized by a state of restlessness associated with unpleasant feelings of irritability and tension. [CTCAE]
MedDRA Code 10001497
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Agitated | Agitation | Agitation aggravated | Agitation mental | Awaking excitability | Discomposure marked | Excitability | Excitable | Excitation | Excitement | Excitement abnormal | Excitement excessive | Frenzy | Hyperexcitability | Hyperexcitability extreme | Hyperexcitation | Increased agitation | Marked discomposure | Nocturnal agitation | Flustered
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00126Amobarbital--
BADD_D00128Amoxapine--
BADD_D00129Amoxicillin--
BADD_D00130Amphetamine0.000634%
BADD_D00132Amphotericin b--
BADD_D00152Apomorphine0.000709%
BADD_D00158Aprotinin (bovine)--
BADD_D00159Arformoterol--
BADD_D00160Arformoterol tartrate--
BADD_D00165Aripiprazole0.006554%
BADD_D00166Aripiprazole lauroxil-
BADD_D00167Armodafinil0.007864%
BADD_D00168Arsenic--
BADD_D00169Arsenic trioxide--
BADD_D00171Ascorbic acid--
BADD_D00172Asenapine0.008010%
BADD_D00176Atazanavir--
BADD_D00178Atenolol0.000252%
BADD_D00180Atomoxetine0.003061%
BADD_D00181Atomoxetine hydrochloride--
BADD_D00182Atorvastatin calcium--
BADD_D00189Atropine0.000482%
BADD_D00190Atropine sulfate--
BADD_D00192Avanafil--
BADD_D00198Azelastine--
BADD_D00203Azithromycin--
BADD_D00204Azithromycin dihydrate--
BADD_D00209Baclofen0.003447%
BADD_D00213Barium sulfate--
BADD_D00214Basiliximab--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 25 Pages
ADReCS-Target
ADR Term Drug Name Target